UK’s MHRA authorises Lilly’s Mounjaro for weight loss
(Reuters) -Britain’s health regulator on Wednesday authorised Eli Lilly’s diabetes drug Mounjaro for weight management and weight loss in the UK, hours after a similar approval in the United States. The Medicines and Healthcare products Regulatory Agency approved the drug for adults aged 18 and over and added that the medicine is to be used …
UK’s MHRA authorises Lilly’s Mounjaro for weight loss Read More »









